414 related articles for article (PubMed ID: 19343870)
1. Discontinuing Alzheimer's disease drug therapy: why, when, and how.
Crutchfield D
Director; 2008; 16(1):19-21. PubMed ID: 19343870
[TBL] [Abstract][Full Text] [Related]
2. Rationale for combination therapy with galantamine and memantine in Alzheimer's disease.
Grossberg GT; Edwards KR; Zhao Q
J Clin Pharmacol; 2006 Jul; 46(7 Suppl 1):17S-26S. PubMed ID: 16809811
[TBL] [Abstract][Full Text] [Related]
3. Contemporary issues in the treatment of Alzheimer's disease: tangible benefits of current therapies.
Tariot PN
J Clin Psychiatry; 2006; 67 Suppl 3():15-22; quiz 23. PubMed ID: 16649847
[TBL] [Abstract][Full Text] [Related]
4. New drugs for Alzheimer's disease in Japan.
Takeda M; Tanaka T; Okochi M
Psychiatry Clin Neurosci; 2011 Aug; 65(5):399-404. PubMed ID: 21851448
[No Abstract] [Full Text] [Related]
5. Realistic expectations for treatment success in Alzheimer's disease.
Geldmacher DS; Frolich L; Doody RS; Erkinjuntti T; Vellas B; Jones RW; Banerjee S; Lin P; Sano M
J Nutr Health Aging; 2006; 10(5):417-29. PubMed ID: 17066215
[TBL] [Abstract][Full Text] [Related]
6. Pharmacology of acetylcholinesterase inhibitors and N-methyl-D-aspartate receptors for combination therapy in the treatment of Alzheimer's disease.
Geerts H; Grossberg GT
J Clin Pharmacol; 2006 Jul; 46(7 Suppl 1):8S-16S. PubMed ID: 16809810
[TBL] [Abstract][Full Text] [Related]
7. [Mechanisms of action of Alzheimer medications].
Alhainen K
Duodecim; 2003; 119(20):1959-66. PubMed ID: 14640001
[No Abstract] [Full Text] [Related]
8. [Pharmacological therapy in Alzheimer's disease. Current clinical practice in The Netherlands].
Schölzel-Dorenbos CJ;
Tijdschr Gerontol Geriatr; 2005 Jul; 36(3):122-6. PubMed ID: 16078659
[TBL] [Abstract][Full Text] [Related]
9. Effective pharmacological management of Alzheimer's disease.
Atri A
Am J Manag Care; 2011 Nov; 17 Suppl 13():S346-55. PubMed ID: 22214392
[TBL] [Abstract][Full Text] [Related]
10. Domain-specific improvement of cognition on memantine in patients with Alzheimer's disease treated with rivastigmine.
Riepe MW; Adler G; Ibach B; Weinkauf B; Tracik F; Gunay I
Dement Geriatr Cogn Disord; 2007; 23(5):301-6. PubMed ID: 17356273
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic treatment options in Alzheimer's disease: optimizing disease management.
Aisen PS
J Am Acad Nurse Pract; 2005 Mar; Suppl():5-7. PubMed ID: 16033023
[TBL] [Abstract][Full Text] [Related]
12. Drug therapy of dementia in elderly patients. A review.
Olsen CE; Poulsen HD; Lublin HK
Nord J Psychiatry; 2005; 59(2):71-7. PubMed ID: 16195103
[TBL] [Abstract][Full Text] [Related]
13. [Therapy of Alzheimer disease].
Kovács T
Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer disease and its management: a review.
Samanta MK; Wilson B; Santhi K; Kumar KP; Suresh B
Am J Ther; 2006; 13(6):516-26. PubMed ID: 17122533
[TBL] [Abstract][Full Text] [Related]
15. Tolerability of memantine in combination with cholinesterase inhibitors in dementia therapy.
Hartmann S; Möbius HJ
Int Clin Psychopharmacol; 2003 Mar; 18(2):81-5. PubMed ID: 12598818
[TBL] [Abstract][Full Text] [Related]
16. Treatment strategies for the behavioral symptoms of Alzheimer's disease: focus on early pharmacologic intervention.
Beier MT
Pharmacotherapy; 2007 Mar; 27(3):399-411. PubMed ID: 17316151
[TBL] [Abstract][Full Text] [Related]
17. [New options for the pharmacotherapy of Alzheimer's disease after the registration of memantine?].
Frölich L; Schmitt B; Calabrese P; Diener H; Förstl H; Gertz HJ; Hallauer JF; Hampel H; Ihl R; Rieke K; Riepe M; Supprian T
Dtsch Med Wochenschr; 2005 Feb; 130(8):408-12. PubMed ID: 15717252
[No Abstract] [Full Text] [Related]
18. Drugs for Alzheimer's disease.
Cranwell-Bruce LA
Medsurg Nurs; 2010; 19(1):51-3. PubMed ID: 20336985
[No Abstract] [Full Text] [Related]
19. Drugs for cognitive loss and dementia.
Treat Guidel Med Lett; 2013 Oct; 11(134):95-100; quiz 1 p following p100.. PubMed ID: 24081314
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer's disease: beware of interactions with cholinesterase inhibitors.
Prescrire Int; 2006 Jun; 15(83):103-6. PubMed ID: 16764099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
